Respiratory syncytial virus vaccine leads to lower infant hospitalisation with laboratory‐confirmed RSV disease compared with placebo (high certainty).
The review found no eligible studies for this question.
Respiratory syncytial virus vaccine showed no clear difference in intrauterine growth restriction compared with placebo (moderate certainty).
Respiratory syncytial virus vaccine showed no clear difference in stillbirth compared with placebo (low certainty).
Respiratory syncytial virus vaccine showed no clear difference in maternal death compared with placebo (low certainty).
It is very uncertain whether respiratory syncytial virus vaccine changes preterm birth compared with placebo (very low certainty).
Respiratory syncytial virus vaccine showed no clear difference in congenital abnormalities compared with placebo (high certainty).
It is very uncertain whether respiratory syncytial virus vaccine changes infant death compared with placebo (very low certainty).